APOE4 status | SNP | Genotype | N | Mean BHB mM | Std Error | Lower 95% | Upper 95% | p-value* |
---|---|---|---|---|---|---|---|---|
Baseline Post-dose (1/2 dose) | ||||||||
E4- | Â | Â | 29 | 0.121 | 0.014 | 0.093 | 0.148 | Â |
E4+ | Â | Â | 38 | 0.161 | 0.012 | 0.137 | 0.185 | 0.030 |
E4- | IL1B rs1143627 | C/C | 3 | 0.103 | 0.032 | 0.037 | 0.170 | Â |
E4- | IL1B rs1143627 | C/T | 9 | 0.126 | 0.019 | 0.087 | 0.164 | Â |
E4- | IL1B rs1143627 | T/T | 14 | 0.120 | 0.015 | 0.089 | 0.151 | 0.838 |
E4- | IDE rs2251101 | C/C | 5 | 0.096 | 0.025 | 0.045 | 0.147 | Â |
E4- | IDE rs2251101 | C/T | 9 | 0.134 | 0.018 | 0.097 | 0.172 | Â |
E4- | IDE rs2251101 | T/T | 15 | 0.121 | 0.014 | 0.091 | 0.150 | 0.471 |
Day 45 Post-dose (full dose) | ||||||||
E4- | Â | Â | 23 | 0.334 | 0.047 | 0.240 | 0.428 | Â |
E4+ | Â | Â | 33 | 0.355 | 0.039 | 0.276 | 0.434 | 0.730 |
E4- | IL1B rs1143627 | C/C | 3 | 0.227 | 0.102 | 0.013 | 0.441 | Â |
E4- | IL1B rs1143627 | C/T | 8 | 0.431 | 0.062 | 0.300 | 0.562 | Â |
E4- | IL1B rs1143627 | T/T | 10 | 0.278 | 0.056 | 0.161 | 0.395 | 0.132 |
E4- | IDE rs2251101 | C/C | 4 | 0.470 | 0.099 | 0.263 | 0.677 | Â |
E4- | IDE rs2251101 | C/T | 6 | 0.315 | 0.081 | 0.146 | 0.484 | Â |
E4- | IDE rs2251101 | T/T | 13 | 0.301 | 0.055 | 0.186 | 0.416 | 0.338 |
Day 90 Post-dose(full dose) | ||||||||
E4- | Â | Â | 20 | 0.301 | 0.076 | 0.147 | 0.454 | Â |
E4+ | Â | Â | 22 | 0.471 | 0.072 | 0.325 | 0.617 | 0.111 |
E4- | IL1B rs1143627 | C/C | 3 | 0.193 | 0.144 | -0.111 | 0.498 | Â |
E4- | IL1B rs1143627 | C/T | 8 | 0.378 | 0.088 | 0.191 | 0.564 | Â |
E4- | IL1B rs1143627 | T/T | 8 | 0.296 | 0.088 | 0.110 | 0.483 | 0.544 |
E4- | IDE rs2251101 | C/C | 4 | 0.123 | 0.113 | -0.116 | 0.361 | Â |
E4- | IDE rs2251101 | C/T | 5 | 0.470 | 0.101 | 0.257 | 0.683 | Â |
E4- | IDE rs2251101 | T/T | 11 | 0.288 | 0.068 | 0.144 | 0.432 | 0.099 |